联系客服

002370 深市 亚太药业


首页 公告 亚太药业:2013年度业绩快报

亚太药业:2013年度业绩快报

公告日期:2014-02-28

                 证券代码:002370             证券简称:亚太药业           公告编号:2014-005      

                                     浙江亚太药业股份有限公司                  

                                            2013年度业绩快报            

                      本公司及董事会全体成员保证信息披露内容的真实、准确和完                       

                 整,没有虚假记载、误导性陈述或重大遗漏。                  

                       特别提示:本公告所载2013年度的财务数据仅为初步核算数据,                      

                 已经公司内部审计部门审计,未经会计师事务所审计,与年度报告中                       

                 披露的最终数据可能存在差异,请投资者注意投资风险。                    

                       一、2013年度主要财务数据和指标            

                                                                                      单位:元 

                                                                                    增减变动幅度

                           项目              本报告期            上年同期            (%)   

                        营业总收入        313,637,218.04       316,044,644.25          -0.76%

                         营业利润          5,923,526.41        -28,639,373.63          120.68%

                         利润总额          5,908,054.80        -31,330,734.18          118.86%

                   归属于上市公司股东的    5,866,860.64        -25,717,528.39          122.81%

                          净利润

                   基本每股收益(元)            0.03                -0.13              123.08%

                   加权平均净资产收益率       0.83%              -3.56%              4.39%

                                                                                    增减变动幅度

                                            本报告期末          本报告期初           (%)   

                         总资产           801,994,532.89       818,018,370.81          -1.96%

                   归属于上市公司股东的   710,212,382.85       703,940,455.73          0.89%

                        所有者权益

                         股   本         204,000,000.00       204,000,000.00          0.00%

                   归属于上市公司股东的        3.48                3.45               0.87%

                     每股净资产(元)  

                 注:上述数据以公司合并报表数据填列。

                                                         1

                       二、经营业绩和财务状况情况说明            

                       1、报告期内,公司实现营业收入313,637,218.04元,较上年同                       

                 期下降0.76%;营业利润5,923,526.41元,较上年同期增长120.68%;                         

                 利润总额5,908,054.80元,较上年同期增长118.86%;归属于母公司                        

                 净利润5,866,860.64元,较上年同期增长122.81%。公司2013年度扭                        

                 亏为盈,一方面,随着市场渠道的调整,公司普药品种市场份额于2013                      

                 年第四季度起开始逐步恢复;另一方面,随着产品结构的调整,优质                        

                 产品收入的增长,公司业绩得到逐步改善。                

                       2、截止2013年12月31日,公司总资产801,994,532.89元,比年                        

                 初下降1.96%;归属于上市公司股东的所有者权益710,212,382.85元,                       

                 比年初增长0.89%。       

                       三、与前次业绩预计的差异说明           

                       公司2013年10月26日披露的《2013年第三季度报告全文》中预计                     

                 归属于上市公司股东净利润与上年同期相比扭亏为盈,增减变动幅度                      

                 为200万元~800万元。         

                       本次业绩快报披露的经营业绩与前次披露的业绩预告不存在重                     

                 大差异。   

                       四、备查文件     

                       1.经公司现任法定代表人、主管会计工作的负责人、会计机构负                     

                 责人签字并盖章的比较式资产负债表和利润表;                

                       2.内部审计部门负责人签字的内部审计报告。               

                                                             浙江亚太药业股份有限公司        

                                                                        董  事  会

                                                                       2014年2月28日    

                                                         2